[Current status of peptic ulcer therapy].
D000863:Antacids / Q000627:therapeutic use; D002229:Carbenoxolone / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000178:diet therapy* / Q000188:drug therapy / Q000601:surgery; D011453:Prostaglandins / Q000627:therapeutic use
D000863:Antacids; D010276:Parasympatholytics; D011453:Prostaglandins; D002792:Cholestyramine Resin; D008787:Metoclopramide; D002229:Carbenoxolone
Derzeitiger Stand der Therapie des peptischen Ulkus.